Relmada Therapeutics, Inc. - Common Stock (NQ:RLMD)

6.420 +0.010 (+0.16%)

Streaming Delayed Price Updated: 10:52 AM EDT, Jul 8, 2026 Add to My Watchlist

Price and Volume

Volume	241,092
Open	6.350
Bid (Size)	6.410 (200)
Ask (Size)	6.430 (500)
Prev. Close	6.410
Today's Range	6.350 - 6.665
52wk Range	0.5500 - 8.000
Shares Outstanding	17,472,986
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Relmada's Cancer Drug Candidate Sparks Fresh Bullish Call ↗

June 18, 2026

HC Wainwright initiates Relmada Therapeutics (NASDAQ: RLMD) with a Buy rating and $12 target, highlighting its bladder cancer potential.

Via Benzinga

Relmada Therapeutics Q1 Earnings Call Highlights ↗

May 12, 2026

Relmada Therapeutics (NASDAQ:RLMD) said it remains on track to begin its Phase 3 RESCUE registrational program for NDV-01 in mid-2026 after reporting 12-month Phase 2 data in non-muscle invasive...

Via MarketBeat

Performance

YTD	+46.9%	+46.9%
1 Month	+12.2%	+12.2%
3 Month	-4.9%	-4.9%
6 Month	+57.4%	+57.4%
1 Year	+952.1%	+952.1%

More News

Relmada (RLMD) Q4 2025 Earnings Call Transcript ↗

March 19, 2026

Via The Motley Fool

Relmada Therapeutics Inc (NASDAQ:RLMD) Reports Q4 2025 Earnings Miss, Stock Declines ↗

March 19, 2026

Via Chartmill

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

Unusual volume stocks in Tuesday's session ↗

March 10, 2026

Via Chartmill

Top stock movements in today's session. ↗

March 09, 2026

Via Chartmill

Monday's session: top gainers and losers ↗

March 09, 2026

Via Chartmill

Gapping stocks in Monday's session ↗

March 09, 2026

Via Chartmill

Wondering what's happening in today's pre-market session? ↗

March 09, 2026

Via Chartmill

RLMD Stock Soars Pre-Market: Phase 2 Bladder Cancer Trial Data Impresses Investors ↗

March 09, 2026

Via Stocktwits

Relmada Therapeutics Inc (NASDAQ:RLMD) Reports Wider-Than-Expected Q3 2025 Loss ↗

November 13, 2025

Via Chartmill

Relmada (RLMD) Q3 2025 Earnings Call Transcript ↗

November 13, 2025

Via The Motley Fool

A Glimpse of Relmada Therapeutics's Earnings Potential ↗

November 12, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 04, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 06, 2025

Via Benzinga

Let's take a look at the stocks that are in motion in today's session. ↗

October 03, 2025

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 03, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 04, 2025

Via Benzinga

On Wednesday, there are stocks with unusual volume. Let's take a look. ↗

September 03, 2025

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 02, 2025

Via Benzinga

Top movers analysis one hour before the close of the markets on 2025-08-29: top gainers and losers in today's session. ↗

August 29, 2025

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 29, 2025

Via Benzinga

Top movers in Friday's session ↗

August 29, 2025

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 29, 2025

Via Benzinga

Frequently Asked Questions

Is Relmada Therapeutics, Inc. - Common Stock publicly traded?

Yes, Relmada Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Relmada Therapeutics, Inc. - Common Stock trade on?

Relmada Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Relmada Therapeutics, Inc. - Common Stock?

The ticker symbol for Relmada Therapeutics, Inc. - Common Stock is RLMD on the Nasdaq Stock Market

What is the current price of Relmada Therapeutics, Inc. - Common Stock?

The current price of Relmada Therapeutics, Inc. - Common Stock is 6.420

When was Relmada Therapeutics, Inc. - Common Stock last traded?

The last trade of Relmada Therapeutics, Inc. - Common Stock was at 07/08/26 10:52 AM ET

What is the market capitalization of Relmada Therapeutics, Inc. - Common Stock?

The market capitalization of Relmada Therapeutics, Inc. - Common Stock is 112.18M

How many shares of Relmada Therapeutics, Inc. - Common Stock are outstanding?

Relmada Therapeutics, Inc. - Common Stock has 112M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.